Reaction Details Report a problem with these data
Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM556317
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
0.500±n/a nM
Citation
 Rai, R; Booth, R; Green, MJ PGDH inhibitors and methods of making and using US Patent  US11345702 Publication Date 5/31/2022 
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Homo sapiens (Human)
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM556317
Synonyms:
US11345702, Table 1.35 | US20230390274, Compound A-87
Type:
Small organic molecule
Emp. Form.:
C20H19ClN2O
Mol. Mass.:
338.831
SMILES:
Clc1cccc(c1)-n1ccc2cc(ccc12)C(=O)N1CCCCC1
Structure:
Search PDB for entries with ligand similarity: